Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-17-041874
Filing Date
2017-06-26
Accepted
2017-06-26 21:18:31
Documents
2
Period of Report
2017-06-26

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2207
2 POA DOCUMENT poa.txt EX-24.3_733233 3005
  Complete submission text file 0001209191-17-041874.txt   6570
Mailing Address 10 MALL ROAD SUITE 301 BURLINGTON MA 01803
Business Address 10 MALL ROAD SUITE 301 BURLINGTON MA 01803 (781) 305-7777
Flexion Therapeutics Inc (Issuer) CIK: 0001419600 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1601 TRAPELO ROAD SUITE 284 WALTHAM MA 02451
Business Address
Levine Mark S. (Reporting) CIK: 0001617236 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36287 | Film No.: 17931027